The primary focus of Dr. Sen's research has been in T-cell based immunotherapy to target malignant melanoma and in the development of novel therapies targeting leukemic stem cells (LSCs) in acute myelogenous leukemia (AML). His specialties include
- Cancer immunology and immunotherapy
- Oncology/cancer stem cell biology and signaling pathways
- In vivo pharmacology studies: Mouse models of leukemia and melanoma
- High throughput screening (HTS)
- Multi-parameter flow cytometry
- Confocal microscopy
